Published in Hospital Law Weekly, September 29th, 2005
"This was a self-controlled prospective cohort study, carried out in a tertiary level hospital. A total of 49 HIV-infected patients were included. They were prescribed HAART according to guidelines," investigators in Spain report.
"After 6 months taking HAART containing didanosine twice daily," said the authors, "patients continued with the same regimen of HAART although once...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.